Public library - UKHSA national
Grŵp cyfyngedig
|
Wedi dechrau - Awst 2018
|
Gweithgaredd diwethaf - Heddiw
Back
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England
Fersiwn 1.3 Cymeradwy
Owner
- Document Type
- Dogfen sylfaenol
- Estyniad
- Maint
- 285 KB
- Wedi'i addasu
- 15/11/2021 13:24 by PHE Publishing
- Creu
- 15/11/2021 09:13 by PHE Publishing
- Graddfeydd
-
0
application/pdf; version=1.7
2021-11-15T13:23:51Z
UKHSA
2021-11-15T13:23:51Z
en-GB
COVID-19; coronavirus; BNT162b2; Comirnaty, Pfizer-BioNTech
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against COVID-19 related symptoms in England: test negative case-control study
application/pdf
2021-11-15T13:23:51Z
COVID-19; coronavirus; BNT162b2; Comirnaty, Pfizer-BioNTech
UKHSA
2021-11-15T13:23:51Z
2021-11-15T13:23:51Z
-
Version 1.3By PHE Publishing, on 15/11/2021 13:24Cofnod Dim Newid
-
Version 1.2By PHE Publishing, on 15/11/2021 09:22Cofnod Dim Newid
-
Version 1.1By PHE Publishing, on 15/11/2021 09:22Cofnod Dim Newid
-
Version 1.0By PHE Publishing, on 15/11/2021 09:13Cofnod Dim Newid